Ignite Creation Date:
2025-12-24 @ 5:35 PM
Ignite Modification Date:
2026-05-18 @ 8:53 AM
Study NCT ID:
NCT04943068
Status:
COMPLETED
Last Update Posted:
2024-11-13
First Post:
2021-06-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)
Sponsor:
Kwang Dong Pharmaceutical co., ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KD-BMT-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None